Study of Programmed Death Ligand 1 and EGFR/HER2 Expression in Non-Small-Cell Lung Carcinoma With a Clinicopathological Spectrum
Article in Cureus (July 2021)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision
Article in Lung Cancer (November 2019)
Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non–Small-Cell Lung Cancer
Article in Clinical Lung Cancer (May 2019)